{"id":"NCT00464945","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants","officialTitle":"A Phase 3, Randomised,Active-Controlled ,Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2008-09","completion":"2008-09","firstPosted":"2007-04-24","resultsPosted":"2012-08-15","lastUpdate":"2012-08-15"},"enrollment":269,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent Pneumococcal Conjugate Vaccine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of manufacturing scale 13-valent pneumococcal conjugate (13vPnC) vaccine compared to pilot scale 13vPnC in healthy infants when given with routine pediatric vaccines.","primaryOutcome":{"measure":"Percentage of Participants Achieving Antibody Level ≥0.35μg/mL in 13vPnC Manufacturing Scale Group Relative to 13vPnC Pilot Scale Group After the 3-Dose Infant Series","timeFrame":"One month after 3-dose infant series (5 months of age)","effectByArm":[{"arm":"13vPnC Manufacturing","deltaMin":97.7,"sd":null},{"arm":"13vPnC Pilot","deltaMin":96.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"41 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["Poland"]},"refs":{"pmids":["21335032"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":134},"commonTop":["Irritability","Erythema (Any)","Erythema (Mild)","Increased sleep","Irritability"]}}